These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf. Thomassen MJ; Antal JM; Divis LT; Wiedemann HP Clin Immunol Immunopathol; 1995 Nov; 77(2):201-5. PubMed ID: 7586728 [TBL] [Abstract][Full Text] [Related]
23. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings. Levine D; Edwards DK; Merritt TA AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824 [TBL] [Abstract][Full Text] [Related]
24. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593 [TBL] [Abstract][Full Text] [Related]
26. Surfactant and respiratory distress syndrome. Milner AD Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619 [TBL] [Abstract][Full Text] [Related]
27. Criteria for use of colfosceril (Exosurf) in neonates. Bhatt-Mehta V; Schumacher RE Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234 [No Abstract] [Full Text] [Related]
28. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria. Scarpelli EM; David E; Cordova M; Mautone AJ Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146 [TBL] [Abstract][Full Text] [Related]
30. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness]. Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392 [TBL] [Abstract][Full Text] [Related]
31. Surfactant therapy in respiratory distress syndrome--the first local experience. Lim NL; Nordin MM; Cheah IG Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989 [TBL] [Abstract][Full Text] [Related]
32. The effect of three surfactant preparations on in vitro lymphocyte functions. Woerndle S; Bartmann P J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541 [TBL] [Abstract][Full Text] [Related]
33. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung. Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208 [TBL] [Abstract][Full Text] [Related]
34. Exosurf enhances adenovirus-mediated gene transfer to alveolar type II cells. Manuel SM; Guo Y; Matalon S Am J Physiol; 1997 Oct; 273(4):L741-8. PubMed ID: 9357848 [TBL] [Abstract][Full Text] [Related]
35. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome. Seppänen M; Kääpä P; Kero P Am J Perinatol; 1994 Nov; 11(6):382-5. PubMed ID: 7857426 [TBL] [Abstract][Full Text] [Related]
37. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Van Bel F; Van de Bor M; Stijnen T; Baan J; Ruys JH Pediatrics; 1989 Nov; 84(5):802-7. PubMed ID: 2677960 [TBL] [Abstract][Full Text] [Related]